Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-c]pyrimidine-2-carboxylate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Benzyl 6-benzyl–5,7–dioxo–6,7–dihydro–5H-[1,3]thiazolo[3,2-c]pyrimidine–2-carboxylate is an experimental small molecule belonging to the benzyloxycarbonyl class of organic compounds. It has a molecular formula of C21H16N2O4S and a molecular weight of approximately 392.4 g/mol. The compound has been studied as an inhibitor of matrix metalloproteinase 3 (MMP3), also known as stromelysin‑1. In enzyme inhibition assays it demonstrated weak inhibitory activity against MMP3 with reported IC50 values in the range of approximately 30 µM to 100 µM. There are no approved medical indications or clinical trials for this compound; it is used primarily in research settings for biochemical studies related to MMP inhibition and structure‑activity relationships.[1][3][4]
- Other names
- benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-thiazolo[3,2-c]pyrimidine-2-carboxylate5H-thiazolo[3,2-c]pyrimidine-2-carboxylic acid, 6,7-dihydro-5,7-dioxo-6-(phenylmethyl)-, phenylmethyl ester449798–64–5 (CAS number)
02
Targets
MMP3 (Matrix metalloproteinase-3)
Beyond the preview
Go deeper on benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-c]pyrimidine-2-carboxylate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-c]pyrimidine-2-carboxylate.